Tom M A Wilkinson

InstitutionUniversity of Southampton
AddressSouthampton
United Kingdom
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 14 Covid-19 publications, with a maximum of 3 publications in January 2021
    All Publications
    Bar chart showing 66 publications over 17 distinct years, with a maximum of 9 publications in 2017
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Vancheeswaran R, Willcox ML, Stuart B, Knight M, Kandil H, Barlow A, Patel MH, Stockham J, O'Neill A, Clark TW, Wilkinson T, Little P, Francis N, Griffiths G, Moore M. Accuracy of rapid point-of-care antibody test in patients with suspected or confirmed COVID-19. J Infect. 2022 01; 84(1):94-118. PMID: 34273411.
      Citations:    Fields:    Translation:Humans
    2. Watson A, Öberg L, Angermann B, Spalluto CM, Hühn M, Burke H, Cellura D, Freeman A, Muthas D, Etal D, Belfield G, Karlsson F, Nordström K, Ostridge K, Staples KJ, Wilkinson T. Dysregulation of COVID-19 related gene expression in the COPD lung. Respir Res. 2021 May 29; 22(1):164. PMID: 34051791.
      Citations: 2     Fields:    Translation:HumansCells
    3. Wallis TJM, Heiden E, Horno J, Welham B, Burke H, Freeman A, Dexter L, Fazleen A, Kong A, McQuitty C, Watson M, Poole S, Brendish NJ, Clark TW, Wilkinson TMA, Jones MG, Marshall BG. Risk factors for persistent abnormality on chest radiographs at 12-weeks post hospitalisation with PCR confirmed COVID-19. Respir Res. 2021 May 21; 22(1):157. PMID: 34020644.
      Citations:    Fields:    Translation:Humans
    4. Page LK, Staples KJ, Spalluto CM, Watson A, Wilkinson TMA. Influence of Hypoxia on the Epithelial-Pathogen Interactions in the Lung: Implications for Respiratory Disease. Front Immunol. 2021; 12:653969. PMID: 33868294.
      Citations: 6     Fields:    Translation:Humans
    5. Burke H, Freeman A, Dushianthan A, Celinski M, Batchelor J, Phan H, Borca F, Kipps C, Thomas GJ, Faust SN, Sheard N, Williams S, Fitzpatrick P, Landers D, Wilkinson T. Research Evaluation Alongside Clinical Treatment in COVID-19 (REACT COVID-19): an observational and biobanking study. BMJ Open. 2021 01 22; 11(1):e043012. PMID: 33483446.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    6. van Haren FMP, Richardson A, Yoon HJ, Artigas A, Laffey JG, Dixon B, Smith R, Vilaseca AB, Barbera RA, Ismail TI, Mahrous RS, Badr M, De Nucci G, Sverdloff C, van Loon LM, Camprubi-Rimblas M, Cosgrave DW, Smoot TL, Staas S, Sann K, Sas C, Belani A, Hillman C, Shute J, Carroll M, Carroll M, Wilkinson T, Carroll M, Singh D, Page C. INHALEd nebulised unfractionated HEParin for the treatment of hospitalised patients with COVID-19 (INHALE-HEP): Protocol and statistical analysis plan for an investigator-initiated international metatrial of randomised studies. Br J Clin Pharmacol. 2021 08; 87(8):3075-3091. PMID: 33377218.
      Citations: 3     Fields:    Translation:Humans
    7. Watson A, Wilkinson TMA. Respiratory viral infections in the elderly. Ther Adv Respir Dis. 2021 Jan-Dec; 15:1753466621995050. PMID: 33749408.
      Citations: 4     Fields:    Translation:Humans
    8. Tree JA, Turnbull JE, Buttigieg KR, Elmore MJ, Coombes N, Hogwood J, Mycroft-West CJ, Lima MA, Skidmore MA, Karlsson R, Chen YH, Yang Z, Spalluto CM, Staples KJ, Yates EA, Gray E, Singh D, Wilkinson T, Page CP, Carroll MW. Unfractionated heparin inhibits live wild type SARS-CoV-2 cell infectivity at therapeutically relevant concentrations. Br J Pharmacol. 2021 02; 178(3):626-635. PMID: 33125711.
      Citations: 22     Fields:    Translation:AnimalsCells
    9. Williams S, Sheard N, Stuart B, Phan HTT, Borca F, Wilkinson TMA, Burke H, Freeman A. Comparisons of early and late presentation to hospital in COVID-19 patients. Respirology. 2021 02; 26(2):204-205. PMID: 33283433.
      Citations:    Fields:    Translation:Humans
    10. Monk PD, Marsden RJ, Tear VJ, Brookes J, Batten TN, Mankowski M, Gabbay FJ, Davies DE, Holgate ST, Ho LP, Clark T, Djukanovic R, Wilkinson TMA. Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Respir Med. 2021 02; 9(2):196-206. PMID: 33189161.
      Citations: 119     Fields:    Translation:HumansCTClinical Trials
    11. Burke H, Freeman A, Cellura DC, Stuart BL, Brendish NJ, Poole S, Borca F, Phan HTT, Sheard N, Williams S, Spalluto CM, Staples KJ, Clark TW, Wilkinson TMA. Inflammatory phenotyping predicts clinical outcome in COVID-19. Respir Res. 2020 Sep 22; 21(1):245. PMID: 32962703.
      Citations: 23     Fields:    Translation:HumansPHPublic Health
    12. Wilkinson T, Dixon R, Page C, Carroll M, Griffiths G, Ho LP, De Soyza A, Felton T, Lewis KE, Lewis KE, Phekoo K, Chalmers JD, Gordon A, McGarvey L, Doherty J, Read RC, Shankar-Hari M, Martinez-Alier N, O'Kelly M, Duncan G, Walles R, Sykes J, Summers C, Singh D. ACCORD: A Multicentre, Seamless, Phase 2 Adaptive Randomisation Platform Study to Assess the Efficacy and Safety of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalised Patients: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jul 31; 21(1):691. PMID: 32736596.
      Citations: 21     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    13. van Haren FMP, Page C, Laffey JG, Artigas A, Camprubi-Rimblas M, Nunes Q, Smith R, Shute J, Carroll M, Carroll M, Tree J, Carroll M, Singh D, Wilkinson T, Dixon B. Nebulised heparin as a treatment for COVID-19: scientific rationale and a call for randomised evidence. Crit Care. 2020 07 22; 24(1):454. PMID: 32698853.
      Citations: 24     Fields:    Translation:HumansPHPublic Health
    14. Tolsgaard MG, Cleland J, Wilkinson T, Ellaway RH. How we make choices and sacrifices in medical education during the COVID-19 pandemic. Med Teach. 2020 07; 42(7):741-743. PMID: 32442052.
      Citations: 19     Fields:    Translation:HumansCellsPHPublic Health
    Wilkinson's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (222)
    Explore
    _
    Co-Authors (150)
    Explore
    _
    Similar People (60)
    Explore
    _